JP2025500525A - システアミン酒石酸塩の製造方法及び得られた生成物 - Google Patents

システアミン酒石酸塩の製造方法及び得られた生成物 Download PDF

Info

Publication number
JP2025500525A
JP2025500525A JP2024538482A JP2024538482A JP2025500525A JP 2025500525 A JP2025500525 A JP 2025500525A JP 2024538482 A JP2024538482 A JP 2024538482A JP 2024538482 A JP2024538482 A JP 2024538482A JP 2025500525 A JP2025500525 A JP 2025500525A
Authority
JP
Japan
Prior art keywords
cysteamine
tartrate
crude
cysteamine tartrate
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538482A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500525A5 (cg-RX-API-DMAC7.html
Inventor
アントネラ ミグリオリーニ,
ミハン, フランチェスコ ヤフテ
フランカ セグナリーニ,
アンジェラ トゥオッツィ,
Original Assignee
レコルダティ インダストリア キミカ エ ファーマセウティカ ソシエタ ペル アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by レコルダティ インダストリア キミカ エ ファーマセウティカ ソシエタ ペル アチオニ filed Critical レコルダティ インダストリア キミカ エ ファーマセウティカ ソシエタ ペル アチオニ
Publication of JP2025500525A publication Critical patent/JP2025500525A/ja
Publication of JP2025500525A5 publication Critical patent/JP2025500525A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/06—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26—Separation; Purification; Stabilisation; Use of additives
    • C07C319/28—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024538482A 2021-12-27 2022-12-23 システアミン酒石酸塩の製造方法及び得られた生成物 Pending JP2025500525A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163266021P 2021-12-27 2021-12-27
US63/266,021 2021-12-27
PCT/EP2022/087828 WO2023126376A2 (en) 2021-12-27 2022-12-23 Process for the preparation of cysteamine bitartrate and product so obtained

Publications (2)

Publication Number Publication Date
JP2025500525A true JP2025500525A (ja) 2025-01-09
JP2025500525A5 JP2025500525A5 (cg-RX-API-DMAC7.html) 2026-01-07

Family

ID=84981754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538482A Pending JP2025500525A (ja) 2021-12-27 2022-12-23 システアミン酒石酸塩の製造方法及び得られた生成物

Country Status (5)

Country Link
US (1) US20230202975A1 (cg-RX-API-DMAC7.html)
EP (1) EP4457210A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025500525A (cg-RX-API-DMAC7.html)
CN (1) CN118488942A (cg-RX-API-DMAC7.html)
WO (1) WO2023126376A2 (cg-RX-API-DMAC7.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011233A (en) 1973-06-28 1977-03-08 Givaudan Corporation 2-methyl-2-(4-methyl-3-pentene-1-yl) thiazolidine
IE49614B1 (en) 1979-07-04 1985-10-30 Sogo Pharm Process for preparing mineral acid salt of cysteamines
ATE15668T1 (de) 1980-12-12 1985-10-15 Fine Organics Ltd Verfahren zur herstellung von thiazolidinderivaten.
DE3742265A1 (de) 1987-12-12 1989-06-22 Basf Ag Verfahren zur herstellung von cysteamin-saeureadditionssalzen
CN106146427A (zh) * 2015-04-13 2016-11-23 安徽兴东化工有限公司 一种制备2,2-二甲基四氢噻唑的方法
IT201600106709A1 (it) 2016-10-24 2018-04-24 Chemelectiva S R L Procedimento per la preparazione di un’ammina solforata
US10251850B2 (en) * 2017-01-11 2019-04-09 Lupin Limited Process for preparation of cysteamine bitartrate
IT201900025186A1 (it) 2019-12-23 2021-06-23 Farmabios Spa Metodo per la purificazione di cisteammina

Also Published As

Publication number Publication date
US20230202975A1 (en) 2023-06-29
WO2023126376A3 (en) 2023-09-14
CN118488942A (zh) 2024-08-13
EP4457210A2 (en) 2024-11-06
WO2023126376A2 (en) 2023-07-06

Similar Documents

Publication Publication Date Title
US8217061B2 (en) Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof
CN110381940B (zh) Ag-10的制备方法、其中间体及其盐
TWI706937B (zh) 製備蛋白質去乙醯酶抑制劑之方法
US20210292276A1 (en) Polymorphic forms of belinostat and processes for preparation thereof
WO2006116953A1 (en) A method for the preparation of tegaserod and slected salts thereof
US20230202975A1 (en) Process for the preparation of cysteamine bitartrate and product so obtained
US20060135565A1 (en) Crystalline form of rabeprazole sodium
JPH0357895B2 (cg-RX-API-DMAC7.html)
EP3281941B1 (en) Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
EP3083552B1 (en) Stable solid forms of enclomiphene and enclomiphene citrate
EA052333B1 (ru) Способ получения битартрата цистеамина и полученный таким образом продукт
EP3083551B1 (en) Crystalline form of tapentadol intermediate
US20100081668A1 (en) Polymorphs of 5--6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof
WO2026044692A1 (en) Crystalline solid forms of indane compounds
JP5234856B2 (ja) Npyy5受容体拮抗作用を有する化合物の結晶
HK40098884A (en) Processes for preparing ag-10, its intermediates, and salts thereof
HK40098883A (en) Processes for preparing ag-10, its intermediates, and salts thereof
JP2025500525A5 (cg-RX-API-DMAC7.html)
HK40003591B (en) Polymorphic forms of belinostat and processes for preparation thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251222

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251223